Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 167

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Prognostic Value of Leukocytosis and Lymphopenia for Coronavirus Disease Severity

Open access
Huang, Glen, Kovalic, Alex J., Graber, Christopher J.·2020·Emerging Infectious Diseases

Abstract

T he incidence of coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has spread rapidly globally; as of March 29, 2020, ≈670,000 cases had been confirmed worldwide (1).COVID-19 is typically a pulmonary infection that can range from mild illness to acute respiratory distress syndrome and multiple organ failure; however, other symptoms such as myalgias and anorexia have been noted (2).Although many ongoing studies are investigating measurement of proinflammatory cytokines and other biomarkers as a way to prognosticate infection severity, we investigated use of 2 easily obtained predictors: lymphopenia and leukocytosis (3). The StudyWe searched 3 major databases-MEDLINE/ PubMed, EMBASE, and CENTRAL (Cochrane Central Register of Controlled Trials)-for clinical studies published December 1, 2019, through March 28, 2020.To broadly identify studies detailing lymphocyte and leukocyte testing among patients with COVID-19, we used the following search criteria: "(COVID-19 OR SARS-CoV-2 OR 2019-NCoV OR HCov-19 OR novel coronavirus) AND (laboratory OR WBC OR lymphocyte)."We prioritized studies that measured lymphocyte and leukocyte counts among patients who had severe or critical cases versus those with mild cases.Severe cases were defined as significant respiratory distress (acute hypoxic respiratory failure, acute respiratory distress syndrome, need for mechanical ventilation, or intensive care unit admission) caused by COVID-19.Our meta-analysis included articles about studies and clinical trials that met the following 4 inclusion criteria: 1) involved adult, human patients; 2) written in English; 3) reported lymphocyte and leukocyte counts for patients; and 4) compared patients with severe versus mild illness.Our meta-analysis excluded articles about studies with the following 9 characteristics: 1) involved nonhuman subjects; 2) written in a language other than English; 3) were not a clinical trial, such as a review paper or letter; 4) were out of the scope of the study question detailed above; 5) did not provide raw data to perform quantitative metaanalysis; 6) involved pediatric patients; 7) did not have the full article available; 8) were duplicates; and 9) were ongoing or not completed.We performed the meta-analysis by using Review Manager software version 5.3 (The Cochrane Collaboration, https://training.cochrane.org).We calculated mean differences (MDs) between groups for continuous variables and reported 95% CIs for both severe and nonsevere cases.If the included studies provided medians and interquartile ranges instead of MDs and SDs, we imputed the MDs and SDs as described previously (4-6) and additionally described in the Cochrane Handbook for Systematic Reviews (7).We considered results statistically insignificant if p>0.05 or if the MD included zero.We assessed statistical heterogeneity by using the I 2 statistic and awarded the following values: 0%-24%, homogeneity; 25%-49%, mild heterogeneity; 50%-74%, moderate heterogeneity; and >75%, high Prognostic Value of Leukocytosis and Lymphopenia for Coronavirus Disease Severity

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3201/eid2608.201160

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 167

Metadata

Authors
Huang, G., Kovalic, A. J., & Graber, C. J.
Venue
Emerging Infectious Diseases
Published
2020-08
Volume
26
Issue
8
Pages
1839-1841
ISSN
  • 1080-6040 (ISSN-L)
  • 1080-6059
OpenAlex
W3021698968
Cited by
167
References
5
FWCI
4.35
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prognostic Value of Leukocytosis and Lymphopenia for Coronavirus Disease Severity. https://app.cochat.ai/papers/10.3201/eid2608.201160
The paper
Huang, G., Kovalic, A. J., & Graber, C. J. (2020). Prognostic Value of Leukocytosis and Lymphopenia for Coronavirus Disease Severity. Emerging Infectious Diseases. https://doi.org/10.3201/eid2608.201160

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.